Safety, pharmacokinetics, and antiviral activity of the cyclophilin inhibitor NIM811 alone or in combination with pegylated interferon in HCV-infected patients receiving 14 days of therapy
Titel:
Safety, pharmacokinetics, and antiviral activity of the cyclophilin inhibitor NIM811 alone or in combination with pegylated interferon in HCV-infected patients receiving 14 days of therapy
Auteur:
Lawitz, Eric Godofsky, Eliot Rouzier, Regine Marbury, Thomas Nguyen, Tuan Ke, June Huang, MeiMei Praestgaard, Jens Serra, Denise Evans, Thomas G.